1. Home
  2. CURR vs EVMN Comparison

CURR vs EVMN Comparison

Compare CURR & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Currenc Group Inc. Ordinary Shares

CURR

Currenc Group Inc. Ordinary Shares

HOLD

Current Price

$3.17

Market Cap

395.2M

ML Signal

HOLD

Logo Evommune Inc.

EVMN

Evommune Inc.

HOLD

Current Price

$12.93

Market Cap

405.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CURR
EVMN
Founded
2013
2020
Country
Singapore
United States
Employees
293
48
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
395.2M
405.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CURR
EVMN
Price
$3.17
$12.93
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$43.88
AVG Volume (30 Days)
110.7K
697.1K
Earning Date
05-19-2026
06-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$14.56
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.29
$10.47
52 Week High
$4.73
$33.20

Technical Indicators

Market Signals
Indicator
CURR
EVMN
Relative Strength Index (RSI) 52.20 37.26
Support Level $2.73 $10.47
Resistance Level $3.66 $21.21
Average True Range (ATR) 0.24 0.75
MACD -0.00 0.34
Stochastic Oscillator 49.58 59.12

Price Performance

Historical Comparison
CURR
EVMN

About CURR Currenc Group Inc. Ordinary Shares

Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It operates into two reportable segments, which are remittance services and sales of airtime, of which maximum revenue is generated from the Remittance segment. Geographically, the group generates the majority of its geographic revenue from Malaysia.

About EVMN Evommune Inc.

Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.

Share on Social Networks: